January 4, 2016 Tuberculosis–Advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers
January 3, 2016 Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations
Toward an Evidence-Based Nonclinical Road Map for Evaluating the Efficacy of New Tuberculosis (TB) Drug Regimens: Proceedings of a Critical Path to TB Drug Regimens-National Institute of Allergy and Infectious Diseases In Vivo Pharmacology Workshop for TB Drug Development
December 31, 2015 Evaluation of the Relative Performance of Drug-Induced Skeletal Muscle Injury Biomarkers in Rats
Practical considerations for the use of clinical outcome assessments (COAs) in pediatric clinical research with examples from pediatric gastroenterology
CPTR’s Relational Sequencing TB Data Platform (ReSeqTB) is highlighted on pages 59 and 60 of UNITAID’s “2015 Tuberculosis Diagnostics Technology and Market Landscape” report.
January 11, 2015 Host-Directed Therapies for Tackling Multi-Drug Resistant Tuberculosis: Learning From the Pasteur-Bechamp Debates
